re: no good news for daytraders
'It would be great if you and some of your medical colleagues could write/email/telephone/petition GSK Australia and ask them what they are doing to prepare an injectable form of Relenza. On present scientific evidence, millions of lives could depend on it.'
I have emailed GSK. So far they have not replied. I wonder if the Taiwanese will be first to produce an IV version which I cannot see as being difficult, probably not much more than mixing it with a buffered saline solution.
BTA Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held